» उद्योग समाचार » China Further Optimizes COVID-19 Prevention and Control Measures

China Further Optimizes COVID-19 Prevention and Control Measures

2022-11-11

China will cut COVID-19 quarantine period for incoming travelers from 10 को 8 दिन, cancel the circuit breaker for inbound flights and no longer determine secondary close contacts of confirmed cases, health authorities said on Friday.

Categories of COVID-risk areas will be adjusted to high and low, from the old tertiary standards of high, medium and low, according to a notice that lays out 20 measures aimed at upgrading disease control measures.

According to the notice released by the State Council’s Joint Prevention and Control Mechanism, international travelers will undergo five days of centralized quarantine plus three days of home-based isolation, compared with the current rule of seven days of centralized isolation plus three days spent at home.

It also stipulates that inbound travelers should not be put into isolation again after finishing the required quarantine period at their first points of entry.

The circuit-breaker mechanism, which bans flight routes if inbound international flights carry COVID-10 cases, will be canceled. Inbound travelers will only need to provide one, rather than two, negative nucleic acid testing results taken 48 hours before boarding.

Quarantine periods for close contacts of confirmed infections have also been reduced from 10 to eight days, while secondary close contacts will no longer be traced.

The notice said that modifying categories of COVID-risk areas is aimed at minimizing the number of people facing travel restrictions.

High-risk areas, यह कहा, will cover residences of infected cases and places where they frequently visit and are at high risk of the virus’s spread. The designation of high-risk areas should be bound to a certain building unit and should not be expanded recklessly. If no new cases are detected for five consecutive days, the high-risk label along with control measures should be lifted promptly.

The notice also requires ramping up stockpiles of COVID-19 drugs and medical equipment, preparing more intensive care unit beds, bolstering booster vaccination rates especially among the elderly and accelerating research of broad-spectrum and multivalent vaccines.

It also vows to heighten crackdown on malpractices such as adopting one-size-fits-all policies or imposing additional curbs, as well as stepping up care for vulnerable groups and stranded groups amid a local outbreak.

 

स्रोत:चाइना डेली

शायद आपको भी पसंद हो

  • श्रेणियाँ

  • हाल के पोस्ट

  • टैग

    टीका चिकित्सक कंठ फाहा न्यूक्लिक एसिड टेस्ट ग्रीवा झाड़ू ऐप्लिकेटर कोविड-19 परीक्षण ओरोफरीन्जियल स्वैब लार कलेक्टर एनपी स्वाब परिवहन माध्यम वीटीएम किट नाक का स्वाब मेडिकल स्वाब नमूना संग्रह स्वाब रक्त संग्रहण ट्यूब नासॉफिरिन्जियल स्वाब मौखिक स्वाब स्त्री रोग स्वाब नासॉफिरिन्जियल स्वैब चीन डीएनए सरवाइकल ब्रश चिकित्सा सफाई झाड़ू सूती पोंछा योनि झाड़ू सैंपलिंग ट्यूब वैक्यूम रक्त संग्रह ट्यूब COVID-19 बाँझ झाड़ू निर्वात पम्प ट्यूब वायरस सैंपलिंग ट्यूब एचपीवी न्यूक्लिक एसिड परीक्षण नॉवल कोरोना वाइरस झुंड झाड़ू नमूना ट्यूब नमूना संग्रह ट्यूब सैंपलिंग स्वाब नमूना संग्रहण फोम झाड़ू वायरस परिवहन माध्यम पट्टी जननांग स्वाब महामारी
  • हमारे बारे में


    मेडिको टेक्नोलॉजी कंपनी, लिमिटेड. चीन में चिकित्सा आपूर्ति की एक पेशेवर निर्माता है, हम नायलॉन फ्लॉक स्वैब का उत्पादन और बिक्री करते हैं, वीटीएम किट, लार संग्रह किट और सीएचजी स्वैब & ऐप्लिकेटर.

  • संपर्क करें

    पता: कमरा 201, 301 और 401 बिल्डिंग ए नंबर 10, बाओ लंबी 5 वीं सड़क, टोंगल समुदाय, बाओलोंग स्ट्रीट, लोंगगैंग जिला,शेन्ज़ेन, गुआंग्डोंग, चीन.

    वेब: www.medicoswab.com

    फ़ोन नंबर: +86 0755-28997664

    ईमेल: info@medicoswab.com